|
|
|
|
|
by gizmo
3713 days ago
|
|
What he called drug research was in reality drug acquisition/market research. His spiel about his intention to do real research to improve abandoned drugs is intentionally unfalsifiable because it's about FUTURE research he promises to do, you know, some years down the road. We're supposed to take his word for it and meanwhile he makes his billions. The reality is that all the executives at Turing were his hedge fund buddies, the investors were other hedge fund buddies and Shkreli made nearly a billion dollars in 3 years with his price-hiking shenanigans. In investor presentations he doesn't even refer to Turing as a pharma business nor does he talk about his planned pharmaceutical research, he presented the business as a pharma-hedgefund-hybrid: an easy way to make boatloads of money. This isn't what you'd expect to see from somebody who is passionate about drug research and curing kids, this is what you expect to see from somebody who cynically exploits a system. That internal correspondence (again, subpoenaed) shows they're like "lol, sucker" whenever an individual pays the list price for their drugs makes it crystal clear how concerned they are about providing a service to humanity. See e.g. http://democrats.oversight.house.gov/sites/democrats.oversig... for some nice quotes |
|